They eliminate the four- to six-month lead times for the organization of egg supplies. They have faster, high-volume start-up times for production. They have higher initial purity. They could supplement seasonal vaccine supplies when multiple strain changes are necessary. They would substantially increase global stockpiles of pandemic influenza vaccines.